作者synlinn (长大之前)
看板pharmacist
标题Re: [申覆] 请教药理学第37题
时间Tue Feb 17 22:44:09 2009
根据Basic & Clinical Pharmacology(9th ed), by Bertram G. Katzung(2004)
p.454
Amantadine is less potent than levodopa and its benefits may be short-lived,
often disappearing after only a few weeks of treatment. Nevertheless, during
that time it may favorably influence the bradykinesia, rigidity, and tremor
of parkinsonism.
上面说明了Amantadine的作用强度较levodopa来得小,疗效也消失得较快。
Amantadine在有颠痫、心衰竭病史的病患上也应慎用,
题干问错误选项,故建议此题答案应更正为(A)(D)。
--
手上只有第九版的,应该可以吧 > <
大家帮忙寄啊~~~
--
※ 发信站: 批踢踢实业坊(ptt.cc)
◆ From: 61.217.214.183
1F:推 sru:这题就万事拜托你了! 02/17 23:56
※ 编辑: synlinn 来自: 61.224.46.202 (02/19 12:16)